Pahr Therapeutics, Inc.
Small-molecule therapeutics targeting aryl hydrocarbon receptor (AhR) signaling to treat pulmonary arterial hypertension
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2025
- Latest Form D
- $4.7M, Jul 2025
- Total capital
- $4.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.7M
- 1 Form D · last Jul 2025
- 15 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$4.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Amanda CreedonExecutive OfficerNamed in SEC Form D filings
- Andrew LevinDirectorNamed in SEC Form D filings
- Atsushi UsamiDirectorNamed in SEC Form D filings
- Ken HorneDirectorNamed in SEC Form D filings
- Neil BuckleyExecutive Officer, Director, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingPolymorphic Compounds And Uses ThereofUSPTOApplication 18921463
- PendingIndole Ahr Inhibitors And Uses ThereofUSPTOApplication 18771297
- PendingCombination Of An Ahr Inhibitor With A Pdx Inhibitor Or DoxorubicineUSPTOApplication 18034461
Show all 6 patent records
- Polymorphic Compounds And Uses ThereofSep 4, 2025 · Application 18921463Pending
- Indole Ahr Inhibitors And Uses ThereofApr 17, 2025 · Application 18771297Pending
- Combination Of An Ahr Inhibitor With A Pdx Inhibitor Or DoxorubicineMay 9, 2024 · Application 18034461Pending
- Ahr Inhibitors And Uses ThereofFeb 9, 2023 · Application 17791608Pending
- Ahr Inhibitors And Uses ThereofJan 26, 2023 · Application 17779893Pending
- Indole Ahr Inhibitors And Uses ThereofMay 12, 2022 · Application 17281395Pending
Related companies, and why
- LATTICE THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- Lipocine Inc.Similar federal contract value in Biotech · null in contracts
- ADMA PLASMA BIOLOGICS, INC.Similar federal contract value in Biotech · null in contracts
- Achelios Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Pulmatrix, Inc.Similar federal contract value in Biotech · null in contracts
- ImmunoVec, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .